subasumstat,Mezagitamab,Daratumumab
takeda,janssen
nct04776018: phase 1/2: a study of tak-981 given with monoclonal antibodies (mabs) in rrmm #mmsm #multiplemyeloma #ims2022 
Multiple Myeloma Education Platform for Myeloma Community